A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE | MicrobiomeTrials← Back to trialsNCT07723976
A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-10-30Est. Completion: 2029-09-04
Enrollment target: 120 participants Other microbiome trials you might be interested in
SLC6A1 Neurodevelopmental Disorder (NDD)Developmental and Epileptic Encephalopathies (DEE)
The overall objective of this prospective longitudinal natural history study is to collect clinical data to characterize…
New York, United StatesEst. completion May 25, 2029
Developmental and Epileptic Encephalopathy
This (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, an…
Little Rock, United StatesCompleted Nov 11, 2027